Living guidelines for inflammatory arthritis: Australian recommendations start with DMARD management   

Australian rheumatologists can now look to living guidelines for localised, evidence-based recommendations on pharmacological management of inflammatory arthritis. The guidelines, developed by an expert panel chaired by Professor Rachelle Buchbinder of ANZMUSC, currently cover DMARD dose reduction and discontinuation strategies for rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis in adult patients, and are expected to ...

Already a member?

Login to keep reading.

© 2021 the limbic